Adenocarcinoma of the Pancreas Completed Phase 1 Trials for Imexon (DB05003)

Also known as: Adenocarcinoma, Pancreatic / Adenocarcinoma of Pancreas / Pancreas Adenocarcinoma / Adenocarcinoma, Pancreas / Pancreatic Adenocarcinoma / Pancreas, Adenocarcinoma / Adenocarcinoma Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00327327Safety Study of Imexon Plus Gemcitabine in Untreated Pancreatic AdenocarcinomaTreatment